Natera to Participate in March Investor Conferences
29 Febbraio 2024 - 2:00PM
Business Wire
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA
testing, today announced that it will participate in the following
investor conferences in March.
- Raymond James 45th Annual Institutional Investors
Conference Tuesday, March 5 at 2:15 pm ET | 11:15 am PT in
Orlando, FL
- TD Cowen 44th Annual Health Care Conference Wednesday,
March 6 at 9:50 am ET | 6:50 am PT in Boston, MA
A live webcast and audio archive of each event may be accessed
through the investor relations section of the Natera website at
investor.natera.com. Replays of the events will be available
shortly following the conferences.
About Natera
Natera™ is a global leader in cell-free DNA testing, dedicated
to oncology, women’s health, and organ health. We aim to make
personalized genetic testing and diagnostics part of the standard
of care to protect health, and inform earlier, more targeted
interventions that help lead to longer, healthier lives. Natera’s
tests are validated by more than 180 peer-reviewed publications
that demonstrate high accuracy. Natera operates ISO 13485-certified
and CAP-accredited laboratories certified under the Clinical
Laboratory Improvement Amendments (CLIA) in Austin, Texas and San
Carlos, California. For more information, visit www.natera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240229781750/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc.,
510-826-2350, investor@natera.com Media: Lesley Bogdanow, VP of
Corporate Communications, Natera, Inc., pr@natera.com
Grafico Azioni Natera (NASDAQ:NTRA)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Natera (NASDAQ:NTRA)
Storico
Da Giu 2023 a Giu 2024